Clinical Trial

ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Evaluate the feasibility of using a chatbot combined with continuous activity monitoring to proactively identify, appropriately triage and help manage patients' symptoms during cancer treatment Determine whether such an early outpatient clinic-based intervention can decrease rates of excess triage visits Correlate changes in activity and early symptom management to emergency department visits, unplanned inpatient hospitalizations and treatment breaks
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2022-04-07; most recent amendment 2026-03-31.
Status change: Recruiting → Active, Not Recruiting 2026-03-31
Status change: Not Yet Recruiting → Recruiting 2023-07-19
Trial Details
NCT Number NCT05318027
Lead Sponsor Abramson Cancer Center at Penn Medicine
Conditions Lung Cancer, Gastrointestinal Cancer, Head and Neck Cancer
Enrollment 70 participants
Start Date 2023-05-22
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-01